Genesis HealthCare (GEN) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/30/2026
- Wall Street ends sharply higher, lifted by soaring Microsoft
- Microsoft surges 8% on strong revenue outlook, maintained capex guidance
- Meta sinks 8% after Q3 revenue forecast misses Wall Street estimates
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- Microsoft rally lifts stocks, 30-year Treasury yield hits 19-year peak
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- Wall Street closes down sharply after Fed holds rates unchanged
- Wall Street ends sharply higher, lifted by soaring Microsoft
- KBR names its Mission Technology Solutions spinoff Trinzic
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
Genesis HealthCare Reports Third Quarter 2015 Results
November 5, 2015 4:12 PM ESTKENNETT SQUARE, Pa., Nov. 5, 2015 /PRNewswire/ --Â
Strong Third Quarter Performance and Growth With Pro Forma1 Adjusted: EBITDAR of $188.8 Million, up 6.3% from Prior Year Quarter EBITDA of $67.2 Million, up 13.1% from Prior Year Quarter Diluted EPS of $0.07 Recent HUD Financing Approval Advances Balance Sheet Restructuring Initiatives; Expected to Improve Annual Free Cash Flow $25 - $30 MillionGenesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United... More
Genesis HealthCare Reports Third Quarter 2015 Results
November 5, 2015 4:04 PM ESTKENNETT SQUARE, Pa., Nov. 5, 2015 /PRNewswire/ --Â
Strong Third Quarter Performance and Growth With Pro Forma1 Adjusted: EBITDAR of $188.8 Million, up 6.3% from Prior Year Quarter EBITDA of $67.2 Million, up 13.1% from Prior Year Quarter Diluted EPS of $0.07 Recent HUD Financing Approval Advances Balance Sheet Restructuring Initiatives; Expected to Improve Annual Free Cash Flow $25 - $30 MillionGenesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United... More
